Takeda Oncology
Christina Kohn is an experienced healthcare professional currently serving as the Expanded Patient Access Manager at Takeda Oncology since April 2023. Previously, Christina held the position of Clinical Trial Project Manager at the Boston VA Research Institute, Inc. from November 2021 to April 2023 and worked as a Clinical Research Coordinator at Johns Hopkins Bloomberg School of Public Health from January 2020 to November 2021. With a strong foundation in clinical research and project management, Christina has been involved in regulatory compliance, study protocol development, and stakeholder communication. Prior experience includes roles as a Medical Device Sales Representative at Exactech and Cartiva, Inc., and various positions in medical assistance and research during academic pursuits at William Paterson University, where a Bachelor of Science in Biology was obtained, followed by a Master of Science in Biotechnology from The Johns Hopkins University.
This person is not in any teams
This person is not in any offices
Takeda Oncology
21 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.